Phase I and Phase II Ocular Metabolic Activities and the Role of Metabolism in Ophthalmic Prodrug and Codrug Design and Delivery

Author： Al-Ghananeem Abeer M. Crooks Peter A.

Publisher： MDPI

E-ISSN： 1420-3049|12|3|373-388

ISSN： 1420-3049

Source： Molecules, Vol.12, Iss.3, 2007-03, pp. : 373-388

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modern Prodrug Design for Targeted Oral Drug Delivery

By Dahan Arik Zimmermann Ellen M. Ben-Shabat Shimon

Molecules, Vol. 19, Iss. 10, 2014-10 ,pp. : 16489-16505

MDPI

Access to resources Recommend Favorite

Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases

By Bachu Rinda Devi Chowdhury Pallabitha Al-Saedi Zahraa H. F. Karla Pradeep K. Boddu Sai H. S.

Pharmaceutics, Vol. 10, Iss. 1, 2018-02 ,pp. : 28-28

MDPI

Access to resources Recommend Favorite

Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis

By Lau Wing Man Heard Charles M. White Alex W.

Pharmaceutics, Vol. 5, Iss. 2, 2013-04 ,pp. : 232-245

MDPI

Access to resources Recommend Favorite

Ophthalmic Drug Delivery in Glaucoma—A Review

By Januleviciene Ingrida Siaudvytyte Lina Barsauskaite Ruta

Pharmaceutics, Vol. 4, Iss. 1, 2012-03 ,pp. : 243-251

MDPI

Access to resources Recommend Favorite

Nanoparticle-Laden Contact Lens for Controlled Ocular Delivery of Prednisolone: Formulation Optimization Using Statistical Experimental Design

By ElShaer Amr Mustafa Shelan Kasar Mohamad Thapa Sapana Ghatora Baljit Alany Raid G.

Pharmaceutics, Vol. 8, Iss. 2, 2016-04 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite